MAPP® App suite has received 510(k) approval from FDA, which means that it can be marketed as a medical device in United States.
This has been a long process that has been completed in August and will allow us to focus on a very developed market with great potential.
We maintain our goal to reach a larger number of Hospitals ensuring Clinical Safety to all Patients receiving care with our apps.
